MDCE is a pharm & medical device research and development outsourcing service company with global clinical trials as its core business. Leveraging the medical research resources and academic influence of Harvard University, we have established a complete overseas service industry chain. We provide customized solutions for Chinese biopharmaceutical and medical device companies to go global. Our services include overseas clinical development strategy and design, overseas clinical trial management and operations, overseas product registration, and overseas commercialization layout. Since its establishment, MDCE has successfully helped over 50 biopharmaceutical and medical device projects land overseas, generating accumulated overseas profits exceeding 16 billion RMB for our clients. Currently, MDCE has its own overseas clinical trial team of over 100 members, collaborating with over 2,000 experts and partnering with more than 100 well-known overseas hospitals across the EU, North America, Australia and New Zealand, Southeast Asia, Japan and South Korea, the Middle East, Africa, and other regions.